HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Ohta Selected Research

Aldehydes

12/2000[Roles of mitochondrial dysfunctions in Alzheimer's disease--contribution of deficiency of ALDH 2].
6/2000Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Ohta Research Topics

Disease

17Neoplasms (Cancer)
05/2015 - 04/2000
12Asthma (Bronchial Asthma)
01/2018 - 01/2001
9Inflammation (Inflammations)
01/2018 - 06/2000
6Parkinson Disease (Parkinson's Disease)
04/2009 - 01/2000
5Prostatic Neoplasms (Prostate Cancer)
01/2002 - 03/2000
4Fibrosis (Cirrhosis)
04/2013 - 11/2001
3Neoplasm Metastasis (Metastasis)
06/2008 - 03/2000
3Breast Neoplasms (Breast Cancer)
11/2006 - 08/2000
3MELAS Syndrome (Syndrome, MELAS)
11/2002 - 02/2000
3Pituitary Neoplasms (Pituitary Adenoma)
01/2002 - 08/2000
3Ischemia
11/2001 - 01/2000
3Alzheimer Disease (Alzheimer's Disease)
12/2000 - 06/2000
2Hypersensitivity (Allergy)
11/2017 - 01/2001
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2016 - 08/2014
2Thromboembolism
02/2010 - 08/2009
2Hypoxia (Hypoxemia)
06/2008 - 08/2006
2Pneumonia (Pneumonitis)
03/2008 - 07/2001
2Lung Neoplasms (Lung Cancer)
03/2008 - 05/2000
2Dyspnea (Shortness of Breath)
03/2008 - 07/2000
2Obesity
08/2006 - 06/2000
2Necrosis
04/2005 - 04/2000
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2005 - 05/2003
2Hemorrhage
05/2003 - 07/2001
2Graft vs Host Disease (Graft-Versus-Host Disease)
02/2003 - 03/2000
2Essential Hypertension
11/2002 - 01/2002
2Carcinoma (Carcinomatosis)
12/2001 - 04/2000
2Hypertrophy
10/2001 - 10/2000
2Mitochondrial Diseases (Mitochondrial Disease)
09/2001 - 02/2000
2MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers)
09/2001 - 02/2000
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
09/2001 - 02/2000
2Rhabdoid Tumor (Rhabdoid Tumors)
09/2001 - 03/2001
2Rheumatoid Arthritis
08/2001 - 08/2001
2Melanoma (Melanoma, Malignant)
05/2001 - 10/2000
2Multiple System Atrophy
05/2001 - 07/2000
2Parkinsonian Disorders (Parkinsonism)
05/2001 - 12/2000
2Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy)
10/2000 - 02/2000
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2018
1Otitis Media with Effusion
02/2018
1Rhinosinusitis
11/2017
1Cholangiocarcinoma
10/2017
1Atherosclerotic Plaque (Atheroma)
09/2015
1Rhabdomyosarcoma
05/2015
1Ewing Sarcoma (Sarcoma, Ewing)
05/2015

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
05/2015 - 02/2000
7PeriostinIBA
01/2018 - 05/2011
7Biomarkers (Surrogate Marker)IBA
01/2018 - 05/2011
5CytokinesIBA
08/2014 - 06/2000
4Monoclonal AntibodiesIBA
10/2016 - 01/2000
4EnzymesIBA
08/2014 - 08/2000
4AntigensIBA
03/2008 - 07/2000
4Prostate-Specific Antigen (Semenogelase)IBA
01/2002 - 01/2001
3AllergensIBA
01/2018 - 04/2006
3Natural Killer Cell ReceptorsIBA
02/2003 - 03/2000
3AminesIBA
01/2003 - 01/2000
3NucleotidesIBA
11/2002 - 02/2000
3Ethylene Glycol (Monoethylene Glycol)IBA
02/2002 - 08/2000
3DipeptidesIBA
02/2002 - 08/2000
3Immunoconjugates (Immunoconjugate)IBA
02/2002 - 08/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2001 - 06/2000
3Transfer RNA (tRNA)IBA
09/2001 - 02/2000
3AnticodonIBA
09/2001 - 02/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 11/2001
2Immunoglobulin E (IgE)IBA
01/2018 - 10/2016
2SteroidsIBA
05/2014 - 04/2000
2GlucocorticoidsIBA
05/2014 - 04/2000
2EdaravoneIBA
02/2010 - 08/2009
2FibrinIBA
02/2010 - 08/2009
2RotenoneIBA
04/2009 - 12/2003
2Indicators and Reagents (Reagents)IBA
01/2009 - 12/2001
2SolutionsIBA
07/2008 - 08/2000
2Messenger RNA (mRNA)IBA
06/2008 - 01/2000
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2007 - 07/2000
2Mitochondrial DNA (mtDNA)IBA
08/2006 - 11/2002
2Leu Transfer RNAIBA
01/2005 - 03/2004
21,2,3,4- tetrahydro- 1- (phenylmethyl)isoquinolineIBA
01/2003 - 07/2001
2Peptides (Polypeptides)IBA
02/2002 - 10/2000
2AgarIBA
01/2002 - 10/2000
2Antihypertensive Agents (Antihypertensives)IBA
01/2002 - 06/2000
2LipidsIBA
10/2001 - 02/2000
2Lys Transfer RNAIBA
09/2001 - 02/2000
2Hormones (Hormone)IBA
09/2001 - 04/2000
2AldehydesIBA
12/2000 - 06/2000
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
11/2000 - 05/2000
2Valine (L-Valine)FDA Link
10/2000 - 08/2000
2DuocarmycinsIBA
10/2000 - 08/2000
2ThermolysinIBA
10/2000 - 08/2000
2HLA-C Antigens (HLA-C)IBA
08/2000 - 03/2000
2Cytochromes c (Cytochrome c)IBA
05/2000 - 01/2000
1Genetic Markers (Genetic Marker)IBA
08/2017
1anti-IgE antibodiesIBA
10/2016
1Omalizumab (Xolair)FDA Link
10/2016
1squamous cell carcinoma-related antigenIBA
06/2016
1ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
09/2015

Therapy/Procedure

3Drug Therapy (Chemotherapy)
11/2006 - 04/2000
3Therapeutics
04/2005 - 04/2000
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2003 - 03/2000
2Radiotherapy
02/2018 - 01/2010
2Prostatectomy (Retropubic Prostatectomy)
01/2002 - 03/2001
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2018
1Pancreaticoduodenectomy
10/2017